Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug
Go back to Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug| (NASDAQ: ABVX) | Delayed: 90.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.23 | 52 Week High | $ | |||
| Open | $90.23 | 52 Week Low | $ | |||
| Day High | $90.23 | P/E | N/A | |||
| Day Low | $90.23 | EPS | $ | |||
| Volume | 5,074 | |||||



